MMED NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

MiniMed Group, Inc. Common Stock · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 16.83 USD
-0.6% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is - below the Trend Line and sits at 62.9% of its 52-week range. The latest completed week returned -0.6%, after a 18.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 46/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: earnings are due in 17d.

Setup score 41 out of 100
Latest Close 16.83 USD 24 Jul 2026
1W Return -0.6% latest completed week
4W Return 18.2% short-term follow-through
12W Return 39.0% quarterly tape
Trend Breadth 0.0% 0 of 21 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 42.86% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.6% Latest completed week; four-week move 18.2%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.86% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 46/100 conviction; expected move 11.4%. News sentiment 51/100 50 relevant articles in the latest sentiment read. Event risk 17d Next report is scheduled for 17 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is - below the Trend Line and sits at 62.9% of its 52-week range. The latest completed week returned -0.6%, after a 18.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1412-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 18.2% over four weeks, 39.0% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.6%
4W18.2%
12W39.0%
26W-
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 76% Model confidence 76%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength6/100Blend of value, momentum, and quality. Underlying universe rank 95; rank 1 is best.
Value15/100Relative valuation strength. Underlying universe rank 86; rank 1 is best.
Quality11/100Profitability and accounting quality. Underlying universe rank 90; rank 1 is best.
Momentum37/100Medium-term price momentum. Underlying universe rank 64; rank 1 is best.
Growth75/100Revenue and earnings growth. Underlying universe rank 26; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework1/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
93.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
54.2%
Gross profit retained from each unit of revenue.
Operating margin
1.6%
Operating profit retained from revenue.
Free-cash-flow margin
0.8%
Free cash flow generated from revenue.
Return on invested capital
1.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
14.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-92.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-11.4%
Net share repurchases relative to market value.
Shareholder yield
-11.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-3.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

MMED shows bullish options pressure with a 46/100 conviction score, put-call volume ratio of 0.32, expected move of 11.4%, and Sharemaestro trend signal inactive.

Conviction46/100
Expected move11.4%
Put/call volume0.32
Pressure44
Speculation41
Volatility72
Trend agreement44
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 50 relevant articles.

5 positive · 44 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings17dNext report is scheduled for 17 Aug 2026; event risk rises as the date approaches.
Options expected move11.4%Nearest-chain priced movement where available.
52-week drawdown-17.8%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2012 weeks finished lower.
Best week+18.2%Week of 5 Jun.
Worst week-14.8%Week of 13 Mar.
Latest week-0.6%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains2
Flat weeks0
Modest losses6
Sharp losses6
Recent vol7.7%13-week weekly-return volatility.
Base vol8.2%52-week weekly-return volatility.
Up/down split8/12Count of positive and negative weeks in the 52-week window.
Average skew8.1% / -5.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape30/100

Trend, activity pressure, participation, and risk combine to a 30/100 tape read.

 Indicator analysis11/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.14; No reversal markers Next-Week ExpectancyNegative 42.86%

Next-week expectancy is negative with a 42.86% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors15/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 87; Small Cap Core rank 77 SVQF1/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 718.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options57/100

MMED shows bullish options pressure with a 46/100 conviction score, put-call volume ratio of 0.32, expected move of 11.4%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 11.4% Sentiment51/100

Weighted news tone is neutral across 50 relevant articles.

MiniMed Group (NASDAQ:MMED) Now Covered by Analysts at UBS Group Insiders50/100

No recent insider transaction evidence is stored.

 Earnings17d

Next report is scheduled for 17 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202616.83 USD-0.6%-14.39 USD0.00-5.1MOff
17 Jul 202616.93 USD10.7%-14.27 USD0.00-7.0MOff
10 Jul 202615.29 USD-1.9%-14.13 USD0.00-3.9MOff
3 Jul 202615.59 USD9.5%-14.07 USD0.00-3.5MOff
26 Jun 202614.24 USD-3.6%-13.98 USD0.00-9.2MOff
19 Jun 202614.77 USD-2.6%-13.96 USD0.00-4.9MOff
12 Jun 202615.16 USD6.5%-13.91 USD0.00-4.7MOff
5 Jun 202614.23 USD18.2%-13.82 USD0.00-6.8MOff
29 May 202612.04 USD1.4%-13.79 USD0.00-2.4MOff
22 May 202611.87 USD9.9%-13.93 USD0.00-3.4MOff
15 May 202610.80 USD-6.7%-14.12 USD0.00-3.8MOff
8 May 202611.57 USD-4.5%-14.45 USD0.00-2.4MOff
1 May 202612.11 USD-8.3%-14.77 USD0.00-3.1MOff
24 Apr 202613.20 USD-8.6%-15.11 USD0.00-3.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.